2024 - Accelerating Translational Research with High-Performance Automated InSituPlex® Assays

In this webinar, the expert speakers will present how InSituPlex® assays provide researchers and Pathologists with robust tools for studying complex biological processes, particularly in the context of cancer research and personalized medicine.
InSituPlex® assays provide sensitivity and specificity of biomarker detection comparable to the current clinical gold standard while enabling a deeper dive into the tissue microenvironment with advanced cellular phenotyping with the co-detection of multiple biomarkers within a single cell.
InSituPlex® technology has transformed multiplexed immunofluorescence assays with the detection of proteomic biomarkers through the use of DNA oligo-labeled primary antibodies, paving the way for advanced biomarker detection with a fast, simple and modular workflow.
The expert speakers will present how the proprietary isometric single-molecule signal amplification mechanism of InSituPlex® technology enables a high dynamic range of biomarker detection, crucial for accurate detection of biomarkers with low or varying expression levels. They will demonstrate how the recent advancements by Ultivue and Leica BioSystems facilitates a simple and robust workflow for gaining high-confidence biological insights at scale with completely validated InSituPlex® assay protocols on Leica BOND RX.
Register for this webinar today to know how InSituPlex® technology can revolutionize translational research and personalized medicine with multiplexed immunofluorescence assays.
Keywords: Clinical Research, CRO, Oncology, Diagnostics, Assay Development, Laboratory Technology, Multiplex Testing, Translational Research, Multiplex Immunofluorescence, Cell & Gene Therapies, Basic Research